Papers
4
Total Citations
71
H-Index
4
About
Tuan-Jen Fang is a pioneering surgeon-scientist whose research centers on minimally invasive surgical techniques for esophageal and head-and-neck cancers, with a particular focus on robotic-assisted procedures and the prevention of recurrent laryngeal nerve (RLN) injury. His landmark contribution is the REVATE trial (2024, 56 citations), a multicentre randomized clinical trial comparing robot-assisted versus video-assisted thoracoscopic oesophagectomy—a study that directly addresses the technically challenging lymph node dissection along the RLN, a procedure linked to vocal cord palsy and pulmonary complications. Fang has further advanced this field through a retrospective study (2023) identifying prognostic factors for recovery from left RLN palsy after McKeown esophagectomy, and a systematic review and meta-analysis (2024) on robot-assisted versus conventional neck dissection. His work also extends to sleep surgery, with a 2025 study evaluating single-port transoral robotic surgery (TORS) for tongue base resection in obstructive sleep apnea, highlighting safety outcomes and perioperative hemorrhage risks. With cumulative citations exceeding 70 across these key papers, Fang’s research directly improves surgical precision, reduces complications, and shapes evidence-based guidelines for robotic surgery in thoracic and head-and-neck oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4